Takeda Pharmaceutical Company Limited (TYO:4502)
Japan
· Delayed Price · Currency is JPY 4,410.00
-63.00 (-1.41%)
At close: Dec 5, 2025
Takeda Pharmaceutical Company Employees
Takeda Pharmaceutical Company had 47,455 employees as of March 31, 2025. The number of employees decreased by 1,826 or -3.71% compared to the previous year.
Employees
47,455
Change (1Y)
-1,826
Growth (1Y)
-3.71%
Revenue / Employee
93.08M JPY
Profits / Employee
696.98K JPY
Market Cap
6,966.01B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Chugai Pharmaceutical | 5,026 |
| HOYA Corporation | 37,909 |
| Daiichi Sankyo Company | 19,765 |
| Otsuka Holdings | 35,338 |
| Astellas Pharma | 13,643 |
| Shionogi & | 4,955 |
| Olympus | 29,297 |
| M3, Inc. | 15,360 |
Takeda Pharmaceutical Company News
- 1 day ago - Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies - PRNewsWire
- 15 days ago - US FDA investigates death tied to Takeda's blood disorder drug - Reuters
- 15 days ago - Takeda blood disorder therapy Adzynma linked to patient death: FDA - Seeking Alpha
- 15 days ago - Innovent, first Chinese firm to market weight-loss drug, joins Hang Seng Index - South China Morning Post
- 17 days ago - Beacon Biosignals Announces Multi-Year Expansion of Strategic Collaboration with Takeda to Advance Narcolepsy Diagnosis and Neurobiomarker Discovery - GlobeNewsWire
- 25 days ago - Neurocrine's Depression Drug Fails Phase 2 Goal But Shows Encouraging Safety Profile - Benzinga
- 4 weeks ago - Takeda Shares Promising Interim Results For Mezagitamab In IgA Nephropathy - Nasdaq
- 4 weeks ago - Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy - Business Wire